SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor targeting the 3C-like protease (3CLpro), with potent inhibitory activity (IC50: 3.8 nM) and 9.0% oral bioavailability (BA), used in COVID-19 research [1].
Molecular Weight:
497.92
CAS Number:
[2913186-57-7]
Formula:
C22H26ClF2N5O4
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted